Methotrexate Injection

DRUG3 trials

Sponsors

Lepu Biopharma Co., Ltd., Assiut University, Cincinnati Eye Institute, Southwest Ohio

Conditions

Nail PsoriasisProliferative VitreoretinopathyRhegmatogenous Retinal DetachmentSquamous Cell Carcinoma of the Head and Neck

Phase 2

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

RecruitingNCT06541574

Cincinnati Eye Institute, Southwest OhioProliferative Vitreoretinopathy, Rhegmatogenous Retinal Detachment

Start: 2024-03-01End: 2026-06-30Target: 860Updated: 2024-09-19

Phase 3

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

RecruitingNCT05751512

Lepu Biopharma Co., Ltd.Squamous Cell Carcinoma of the Head and Neck

Start: 2023-04-04End: 2027-12-01Target: 180Updated: 2026-09-04

Unknown Phase

Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis

Assiut UniversityNail Psoriasis

Start: 2023-12-01End: 2025-03-01Target: 20Updated: 2023-12-01